March 7, 2019 | Michael Easterling
Australian lobster fisherman David Thompson traveled 9,000 miles for treatment at City of Hope after being diagnosed with Stage 4 oropharyngeal cancer. Given just six weeks to live, he is thriving more than a year after participating in an immunotherapy clinical trial.
15,000 second chances
April 22, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
TGen IDs gene associated with most common liver cancer
April 19, 2019 | City of Hope
AKR1B10 could help provide early detection of hepatocellular carcinoma, and play a role in monitoring and treating this growing cause of cancer death.
Clinical social workers and the science of caring
April 17, 2019 | Bob Young
Clinical social workers identify sources of distress and teach coping skills to manage the challenges that come with treatment. They also connect patients to community resources for mental health services, as well as financial and transportation assistance.
Combined immunotherapy could tackle advanced cancers
April 15, 2019 | Zen Vuong
City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.
People miss key area of face with sunscreen products, study finds
April 11, 2019 | Samantha Bonar
People commonly miss their eyelids when applying sunscreen or moisturizers containing SPF. This is of concern because this fragile area is prone to skin cancer.
Disney pals entertain pediatric patients during ToyFest
April 8, 2019 | Michael Easterling
The pediatric patients in treatment at City of Hope are unable to go to Disneyland, so on March 14 Disneyland came to them, at the fourth annual winter ToyFest held on City of Hope’s main campus in Duarte, California.
City of Hope to participate in NCI-MATCH clinical trial
April 5, 2019 | City of Hope
City of Hope’s Clinical Molecular Diagnostic Laboratory (CMDL) is participating as a CLIA-Certified/Accredited laboratory in the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial.
City of Hope awarded $7.5M to develop treatment for rare cancer
April 3, 2019 | Zen Vuong
City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma.
City of Hope study finds diabetes A1c test misses most cases
March 28, 2019 | City of Hope
The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes but it is actually unable to detect the disease in most patients, according to a new study presented March 23 at the Endocrine Society’s annual meeting.